Fitch Upgrades Teva to Investment Grade Amid Pivot to Growth Execution

SunCar Technology Forecasting Its Third Consecutive Quarter of Profitability in Q1 2026 and Year-over-Year Revenue Growth of 25%

Arbor Realty Trust Successfully Redeems a Legacy CLO

Esquire Bank Ranks #1 in Raymond James Community Bankers Cup, Earning Recognition for Eighth Consecutive Year

PSEG Foundation Continues Legacy of Supporting Communities and Invites New Jersey and Long Island Nonprofits to Apply for Neighborhood Partners Program Grants

Alto Ingredients, Inc. to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference

Fortress Biotech to Participate in A.G.P.’s Annual Virtual Healthcare Conference

Quantum Cyber Launches Quantum Drones Corporation to Advance U.S. Federal Defense Procurement Strategy and Autonomous Warfare Capabilities

Elis: Disclosure of the number of shares forming the capital and of the total number of voting rights as of 30 04 2026

AMC Theatres® Expands Feature Fare Menu Nationwide With New Craveable Favorites Including Street Corn Poppers, Hot Honey Sausage Pizza, and Popcorn Chicken

Ocean Power Technologies Expands U.S. and International Deployment Footprint

Maris-Tech Completes Development of Peridot Night Micro for AI-Enhanced Situational Awareness

Alpha Cash is Live - Alpha Modus Unleashes a Fintech App Aimed at the $347 Billion Broken Banking Machine

YY Group (NASDAQ: YYGH) Expands Malaysia Operations to Melaka, Entering New High-Growth Hospitality Market

Turn Therapeutics Appoints Physician-Scientist and Former FDA Commissioner, Dr. Stephen M. Hahn, as Executive Clinical and Regulatory Lead

Ameresco's Kūpono Project Named Winner in 2026 Environment+Energy Leader Awards

Myseum.AI Highlights Continuing Progress on AI Development Roadmap, Technology Advancements and Growth Initiatives in Letter to Shareholders

Safe Pro Awarded Additional U.S. Government Subcontract Modification for Extended Support of AI Powered Edge Processing Systems

Lakewood-Amedex Biotherapeutics Announces Positive Data for the Advancement of Lead Candidate, Nu-3, in Infected Diabetic Foot Ulcers

Protara Therapeutics to Host Virtual Investor Webinar to Discuss TARA-002 for Lymphatic Malformations on Tuesday, May 19, 2026